Post-earnings recap
Reported
Thu, Oct 27, 2022
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Edwards Lifesciences reported an EPS of $0.61, slightly missing expectations. The stock reacted negatively, declining by 0.53%. The lack of revenue data and management commentary leaves investors without a clear direction for the company's future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.61 | N/A | -1.93% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.